Clinical trials: in Venezuela
Low Back Pain
Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain
Primary Objective : To demonstrate the superiority of the oral fixed - combination of a muscle relaxant, thiocolchicoside (TCC) to a non steroidal anti-inflammatory drug, ketoprofen, over oral TCC, on average pain within the last…
- Trial name
- TIOKET (NCT00679146)
- Testing
- Thiocolchicoside+Ketoprofen, Thiocolchicoside
- Where
- 6 sites in Brazil, Colombia and 4 more
- Volunteers
- 334 people
- Sponsor
- Sanofi
Febrile Neutropenia
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
- Trial name
- NCT00035425
- Testing
- linezolid, vancomycin
- Where
- 40 sites in United States, Argentina and 8 more
- Volunteers
- 120 people
- Sponsor
- Pfizer
NSCLC
Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
This study is being carried out to see if adding ZD1839 to other standard supportive care is more effective than standard supportive care alone for the treatment of patients with NSCLC whose disease has recurred after previous…
- Trial name
- NCT00242801
- Testing
- Gefitinib
- Where
- 211 sites in Argentina, Australia and 30 more
- Volunteers
- 1,692 people
- Sponsor
- AstraZeneca
Pneumonia
Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia
Primary Objective: The primary objective of the study is to demonstrate the non-inferiority in clinical efficacy at the test of cure (TOC) visit planned 5-7 days after treatment completion of levofloxacin 750 mg once daily (od)…
- Trial name
- NCT00253955
- Testing
- Levofloxacin, Piperacillin/Tazobactam
- Where
- 17 sites in Austria, Belgium and 15 more
- Volunteers
- 460 people
- Sponsor
- Sanofi
Low Back Pain
Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain
The pain relief, safety, and tolerability of valdecoxib 40 mg once daily compared with diclofenac 75 mg twice daily for acute low back pain was studied.
- Trial name
- NCT00649610
- Testing
- valdecoxib, diclofenac
- Where
- 29 sites in Argentina, Brazil and 7 more
- Volunteers
- 340 people
- Sponsor
- Pfizer
Breast Cancer
A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer
This is a non-randomized Phase 2 study testing pemetrexed and doxorubicin in combination for locally advanced or metastatic breast cancer.
- Trial name
- NCT00102219
- Testing
- Pemetrexed, Doxorubicin
- Where
- 12 sites in Brazil, Greece and 5 more
- Volunteers
- 77 people
- Sponsor
- Eli Lilly and Company
Pancreatic Neoplasms, Metastases, Neoplasm
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
Definition: This study will compare the drug GEMZAR to a combination of GEMZAR plus ALIMTA for the treatment of cancer of the pancreas.
- Trial name
- NCT00035035
- Testing
- GEMZAR, ALIMTA
- Where
- 114 sites in United States, Argentina and 16 more
- Sponsor
- Eli Lilly and Company
Schizophrenia
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia
- Trial name
- NCT00036088
- Testing
- Olanzapine
- Where
- 60 sites in United States, Argentina and 10 more
- Volunteers
- 530 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Candidiasis, Oral, HIV Infections
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
The purpose of this study is to compare the safety and effectiveness of SCH 56592 with that of fluconazole in the treatment of OPC (a fungal infection of the throat) in HIV-positive patients.
- Trial name
- NCT00002399
- Testing
- Posaconazole, Fluconazole
- Where
- 53 sites in United States, Argentina and 16 more
- Volunteers
- 500 people
- Sponsor
- Schering-Plough